New Drug Shows Potential for Blood Cancer
Multiple myeloma patients saw survival gains when elotuzumab was added to treatmentContinue Reading
Multiple myeloma patients saw survival gains when elotuzumab was added to treatmentContinue Reading
Experts say findings make sense, but note they are preliminaryContinue Reading
Women account for two-thirds of cases, likely due to unsafe tanning, researchers sayContinue Reading
New research suggests different treatment may be warrantedContinue Reading
It’s one more potential benefit for breast-fed babies, research suggestsContinue Reading
In study, patients who ate typical ‘Western’ fare had more than twice the odds of dying from the diseaseContinue Reading
A depressed caregiver raises odds of depression in ill loved one, too, study showsContinue Reading
Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effectsContinue Reading
Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study findsContinue Reading
Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study findsContinue Reading
Compared to Yervoy, nivolumab more than doubled time to disease progression, researchers foundContinue Reading
DNA-modified virus serves as decoy to help target and destroy glioblastoma cells, researchers sayContinue Reading
Fewer die of ‘late effects’ from radiation, chemotherapy, study findsContinue Reading
Adding Ibrance to standard hormone therapy kept disease from progressing for nine monthsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.